Ke Men
Impact in
- Drug Discovery top 0.5%
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 24
- Nanoparticle-Based Drug Delivery 24
-
- RNA Interference and Gene Delivery 35
- CRISPR and Genetic Engineering 3
- Co-authors
- Maling Gou (21 shared papers)Zhiyong Qian (19 shared papers)Yuquan Wei (25 shared papers)Xingmei Duan (28 shared papers)Feng Luo (12 shared papers)Sibei Lei (14 shared papers)Jia Tao Song (3 shared papers)Xueyan Zhang (12 shared papers)
In The Last Decade
Ke Men
76 papers receiving 3k citations
Peers
Comparison fields: 5 of 96
- Drug Discovery 67
- Biomaterials 1.1k
- Pharmaceutical Science 383
- Molecular Medicine 344
- Immunology 287
Countries citing papers authored by Ke Men
This map shows the geographic impact of Ke Men's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Men with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Men more than expected).
Fields of papers citing papers by Ke Men
This network shows the impact of papers produced by Ke Men. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Men. The network helps show where Ke Men may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Men, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 384 | |
| 2 | 2012 | 161 | |
| 3 | 2009 | 108 | |
| 4 | 2009 | 102 | |
| 5 | 2011 | 96 | |
| 6 | 2021 | 90 | |
| 7 | 2019 | 89 | |
| 8 | 2022 | 86 | |
| 9 | 2010 | 84 | |
| 10 | 2020 | 84 | |
| 11 | 2009 | 80 | |
| 12 | 2010 | 75 | |
| 13 | 2009 | 73 | |
| 14 | 2012 | 72 | |
| 15 | 2020 | 71 | |
| 16 | 2008 | 66 | |
| 17 | 2016 | 61 | |
| 18 | 2014 | 60 | |
| 19 | 2024 | 58 | |
| 20 | 2023 | 56 |
About Ke Men
Ke Men is a scholar working on Biomaterials, Molecular Biology, Immunology, Molecular Medicine and Pharmaceutical Science, having authored 76 papers that have together received 3.1k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (35 papers), Nanoparticle-Based Drug Delivery (24 papers), Immunotherapy and Immune Responses (7 papers), Advanced Drug Delivery Systems (4 papers), Hydrogels: synthesis, properties, applications (3 papers), CRISPR and Genetic Engineering (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Drug Discovery (67 citations), Biomaterials (1.1k citations), Pharmaceutical Science (383 citations), Molecular Medicine (344 citations) and Immunology (287 citations). Ke Men has collaborated with scholars based in China and Macao. Frequent co-authors include Maling Gou, Zhiyong Qian, Yuquan Wei, Xingmei Duan, Feng Luo, Sibei Lei, Jia Tao Song, Xueyan Zhang, Shi H and Yan Gao. Their work appears in journals such as International Journal of Nanomedicine, Journal of Biomedical Nanotechnology, Molecular Pharmaceutics, Nanoscale and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.